Corient Capital Partners, LLC Idexx Laboratories Inc Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 3,420 shares of IDXX stock, worth $1.46 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,420
Previous 3,391
0.86%
Holding current value
$1.46 Million
Previous $1.19 Million
0.84%
% of portfolio
0.09%
Previous 0.09%
Shares
13 transactions
Others Institutions Holding IDXX
# of Institutions
1,213Shares Held
73.3MCall Options Held
167KPut Options Held
343K-
Vanguard Group Inc Valley Forge, PA9.7MShares$4.14 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$4.1 Billion0.11% of portfolio
-
State Street Corp Boston, MA3.61MShares$1.54 Billion0.08% of portfolio
-
Alliancebernstein L.P. New York, NY2.82MShares$1.2 Billion0.5% of portfolio
-
Terry Smith Fundsmith LLP | London, X02.66MShares$1.14 Billion5.45% of portfolio
About IDEXX LABORATORIES INC
- Ticker IDXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 83,253,696
- Market Cap $35.6B
- Description
- IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...